Anti-Recombinant-SARS-CoV-2 Nucleocapsid protein antibody [22F9], Unconjugated, Human, Monoclonal
Artikelnummer:
NBS-ASJ-BYQUQR-100
| Artikelname: |
Anti-Recombinant-SARS-CoV-2 Nucleocapsid protein antibody [22F9], Unconjugated, Human, Monoclonal |
| Artikelnummer: |
NBS-ASJ-BYQUQR-100 |
| Hersteller Artikelnummer: |
ASJ-BYQUQR-100 |
| Alternativnummer: |
NBS-ASJ-BYQUQR-100 |
| Hersteller: |
Nordic BioSite |
| Wirt: |
Human |
| Kategorie: |
Antikörper |
| Applikation: |
ELISA, WB |
| Spezies Reaktivität: |
Virus |
| Immunogen: |
Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based proprietary suspension cell line. Nucleocapsid protein SARS-CoV-2 |
| Konjugation: |
Unconjugated |
| Alternative Synonym: |
COVID19, COV2, SARS-COV, CORONA, COVID, COVID-19, SARS-COV-2, COV-2, NCOV |
| Klonalität: |
Monoclonal |
| Klon-Bezeichnung: |
[22F9] |
| Isotyp: |
IgG1 l |
| Puffer: |
PBS pH 7.4 |
| Quelle: |
human |
| Reinheit: |
Protein A Purified |
| Target-Kategorie: |
Recombinant-SARS-CoV-2 Nucleocapsid protein |
| Antibody Type: |
Primary Antibody |
| Anwendungsbeschreibung: |
ELISA 0.08-0.16 µg/ml |
